Drugs / Daivobet
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01946386 | Sep → Oct 2013 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01607853 | Jun → Oct 2012 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Phase 2 | NCT00845481 | Jan → Mar 2009 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06327620 | Jan 2022 → May 2024 | lichen planus | Mansoura University | Unknown | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT02416258 Comparator | Apr → Jun 2015 | connective tissue disorder | LEO Pharma | Completed | No outcome recorded |
| Phase 2 | NCT01347255 Comparator | May → Jun 2011 | psoriasis | LEO Pharma | Completed | Met primary |
| Phase 2 | NCT00875277 Comparator | Apr → May 2009 | psoriasis | LEO Pharma | Completed | Met primary |
| Phase 3 | NCT05919082 Comparator | Jun 2023 → Feb 2024 | psoriasis | LEO Pharma | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Daivobet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00845481 ↗ |
| Known as | Daivobet ointment | “Daivobet Ointment: This intervention involves the topical application of Daivobet ointment, which is a combination of calcipotriol and betamethasone.” NCT06327620 ↗ |
| Route | Topical | “for Topical Use” NCT00845481 ↗ |